Jarjanazi H - Search Results

1

Associations of the Insertion/Deletion Polymorphism in the ACE Gene and Risk of Gastric Cancer: A Meta-Analysis.

Pabalan N, Jarjanazi H, Ozcelik H. Pabalan N, et al. Among authors: jarjanazi h. J Gastrointest Cancer. 2015 Dec;46(4):370-9. doi: 10.1007/s12029-015-9754-8. J Gastrointest Cancer. 2015. PMID: 26307111

2

Modified rapid expansion detection method to analyze Cag/CTG repeat expansions.

Jarjanazi H, Ozcelik H. Jarjanazi H, et al. Biotechniques. 2002 May;32(5):1006, 1008, 1010. doi: 10.2144/02325bm06. Biotechniques. 2002. PMID: 12019772 Free article. No abstract available.

3

Functional nsSNPs from carcinogenesis-related genes expressed in breast tissue: potential breast cancer risk alleles and their distribution across human populations.

Savas S, Schmidt S, Jarjanazi H, Ozcelik H. Savas S, et al. Among authors: jarjanazi h. Hum Genomics. 2006 Mar;2(5):287-96. doi: 10.1186/1479-7364-2-5-287. Hum Genomics. 2006. PMID: 16595073 Free PMC article.

4

Genome wide screening of CAG trinucleotide repeat lengths in breast cancer.

Jarjanazi H, Li H, Andrulis IL, Ozcelik H. Jarjanazi H, et al. Dis Markers. 2006;22(5-6):343-9. doi: 10.1155/2006/951857. Dis Markers. 2006. PMID: 17264405 Free PMC article.

5

Biological implications of SNPs in signal peptide domains of human proteins.

Jarjanazi H, Savas S, Pabalan N, Dennis JW, Ozcelik H. Jarjanazi H, et al. Proteins. 2008 Feb 1;70(2):394-403. doi: 10.1002/prot.21548. Proteins. 2008. PMID: 17680692

6

Discovery of genetic profiles impacting response to chemotherapy: application to gemcitabine.

Jarjanazi H, Kiefer J, Savas S, Briollais L, Tuzmen S, Pabalan N, Ibrahim-Zada I, Mousses S, Ozcelik H. Jarjanazi H, et al. Hum Mutat. 2008 Apr;29(4):461-7. doi: 10.1002/humu.20732. Hum Mutat. 2008. PMID: 18330920

7

Cyclin D1 Pro241Pro (CCND1-G870A) polymorphism is associated with increased cancer risk in human populations: a meta-analysis.

Pabalan N, Bapat B, Sung L, Jarjanazi H, Francisco-Pabalan O, Ozcelik H. Pabalan N, et al. Among authors: jarjanazi h. Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2773-81. doi: 10.1158/1055-9965.EPI-08-0169. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18843022

8

Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer.

Pabalan N, Francisco-Pabalan O, Sung L, Jarjanazi H, Ozcelik H. Pabalan N, et al. Among authors: jarjanazi h. Breast Cancer Res Treat. 2010 Nov;124(2):531-41. doi: 10.1007/s10549-010-0863-6. Epub 2010 Apr 9. Breast Cancer Res Treat. 2010. PMID: 20379847

9

A whole-genome SNP association study of NCI60 cell line panel indicates a role of Ca2+ signaling in selenium resistance.

Savas S, Briollais L, Ibrahim-zada I, Jarjanazi H, Choi YH, Musquera M, Fleshner N, Venkateswaran V, Ozcelik H. Savas S, et al. Among authors: jarjanazi h. PLoS One. 2010 Sep 7;5(9):e12601. doi: 10.1371/journal.pone.0012601. PLoS One. 2010. PMID: 20830292 Free PMC article.

10

Bioinformatic analyses identifies novel protein-coding pharmacogenomic markers associated with paclitaxel sensitivity in NCI60 cancer cell lines.

Eng L, Ibrahim-zada I, Jarjanazi H, Savas S, Meschian M, Pritchard KI, Ozcelik H. Eng L, et al. Among authors: jarjanazi h. BMC Med Genomics. 2011 Feb 11;4:18. doi: 10.1186/1755-8794-4-18. BMC Med Genomics. 2011. PMID: 21314952 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters